Xencor (XNCR)
(Delayed Data from NSDQ)
$21.07 USD
-0.13 (-0.61%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $21.07 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 41 - 60 ( 221 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Xencor Finishes a Solid 4Q21; Bispecific Programs Ramp Up in 2022; Reiterate Buy and Reduce PT from $61 to $55
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Xencor Previews Corporate Priorities and Milestones for 2022; Reiterate Buy and $61PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
HEALTHCARE- The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department